GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

GSK

1,858.5

-0.83%↓

Home・Stock List・Haleon PLC
Search

Haleon PLC

Closed

SectorHealthcare

343.7 1.06

Buy

Price update 1 May 2026, 15:29 UTC

BuySell

Overview

Share price change

24h

Current

Min

341.1

Max

343.8

Key metrics

By Trading Economics

Income

403M

Sales

2.7B

P/E

Sector Avg

17.216

51.415

EPS

0.044

Dividend yield

2.14

Profit margin

14.708

Employees

24,535

EBITDA

697M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+29.65% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.14%

2.34%

Next Earnings

30 Jul 2026

Next Ex Dividend date

13 Aug 2026

Market Stats

By TradingEconomics

Market Cap

29B

Previous open

342.64

Previous close

343.7

News Sentiment

By Acuity

46%

54%

144 / 345 Healthcare

Haleon PLC Chart

Past performance is not a reliable indicator of future results.

Related News

29 Apr 2026, 07:48 UTC

Earnings

Sensodyne-Maker Haleon Revenue Rises on Oral Health Growth -- Update

DJ

Read

29 Apr 2026, 06:39 UTC

Earnings

Sensodyne-maker Haleon Revenue Rises on Oral Health Growth

DJ

Read

25 Feb 2026, 07:55 UTC

Earnings

Panadol Maker Haleon Reports Revenue Slowdown Amid Weak Cold-And-Flu Season

DJ

Read

29 Apr 2026, 08:05 UTC

Market Talk
Earnings

Haleon's North America Results Were Encouraging -- Market Talk

DJ

Read

29 Apr 2026, 07:46 UTC

Market Talk
Earnings

Haleon's First-Quarter Results Align With Peers -- Market Talk

DJ

Read

29 Apr 2026, 06:07 UTC

Earnings

Haleon: 1Q Emerging Markets Revenue Growth 4.3%

DJ

Read

29 Apr 2026, 06:06 UTC

Earnings

Haleon: Q1 North America Organic Revenue Growth 1.0%

DJ

Read

29 Apr 2026, 06:05 UTC

Earnings

Haleon 1Q Reported Revenue Growth 0.1%

DJ

Read

29 Apr 2026, 06:04 UTC

Earnings

Analysts Saw Haleon 1Q Organic Revenue Growth 2.3%

DJ

Read

29 Apr 2026, 06:04 UTC

Earnings

Haleon 1Q Organic Revenue Growth 2.2%

DJ

Read

29 Apr 2026, 06:04 UTC

Earnings

Haleon 1Q Rev GBP2.86B

DJ

Read

29 Apr 2026, 06:04 UTC

Earnings

Haleon Sees High-single Digit Adjusted Operating Profit Growth at Constant Currency in Medium Term

DJ

Read

29 Apr 2026, 06:03 UTC

Earnings

Haleon Sees 4% to 6% Organic Rev Growth in Medium Term

DJ

Read

29 Apr 2026, 06:03 UTC

Earnings

Haleon Expects a Broadly Neutral Foreign Exchange Translation Impact on Net Rev, Adj Oper Pft

DJ

Read

29 Apr 2026, 06:02 UTC

Earnings

Haleon Sees 2026 Adjusted Effective Tax Rate c.24.5%

DJ

Read

29 Apr 2026, 06:02 UTC

Earnings

Haleon: Sees 2026 Net Interest GBP255 Million

DJ

Read

29 Apr 2026, 06:02 UTC

Earnings

Haleon Sees 2026 High-single Digit Adj Oper Pft Growth at Constant Currency

DJ

Read

29 Apr 2026, 06:01 UTC

Earnings

Haleon Sees 2026 Organic Revenue Growth 3% to 5%

DJ

Read

25 Feb 2026, 07:18 UTC

Earnings

Haleon 4Q Organic Revenue Growth 2.1%

DJ

Read

25 Feb 2026, 07:17 UTC

Earnings

Haleon: GBP500M Allocated to Share Buybacks in 2026

DJ

Read

25 Feb 2026, 07:16 UTC

Earnings

Haleon Sees 2026 High Single Digit Adj. Operating Profit Growth at Constant Currency

DJ

Read

25 Feb 2026, 07:15 UTC

Earnings

Haleon Sees 2026 Organic Revenue Growth of 3% to 5%

DJ

Read

25 Feb 2026, 07:06 UTC

Earnings

Haleon Declares Final Dividend of 4.9p

DJ

Read

25 Feb 2026, 07:05 UTC

Earnings

Haleon 2025 Net Pft GBP1.67B

DJ

Read

25 Feb 2026, 07:05 UTC

Earnings

Haleon 2025 Pretax Pft GBP2.15B

DJ

Read

25 Feb 2026, 07:04 UTC

Earnings

Analysts Saw Haleon 2025 Adj Oper Pft at GBP2.46B

DJ

Read

25 Feb 2026, 07:04 UTC

Earnings

Analysts Saw Haleon 2025 Adj Oper Pft Margin at 22.3%

DJ

Read

25 Feb 2026, 07:04 UTC

Earnings

Analysts Saw Haleon 2025 Organic Revenue Growth at 3.4%

DJ

Read

25 Feb 2026, 07:04 UTC

Earnings

Analysts Saw Haleon 2025 Rev at GBP11.03B

DJ

Read

25 Feb 2026, 07:04 UTC

Earnings

Haleon 2025 Adj. Operating Pft Margin 22.9%

DJ

Read

Peer Comparison

Price change

Haleon PLC Forecast

Price Target

By TipRanks

29.65% upside

12 Months Forecast

Average 426.67 GBX  29.65%

High 512 GBX

Low 325 GBX

Based on 10 Wall Street analysts offering 12 month price targets forHaleon PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

7

Buy

2

Hold

1

Sell

Based on 10 analysts giving stock ratings to Haleon PLC - Dist in the past 3 months.

Sentiment

By Acuity

144 / 345 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Other stocks from the sector

GSK

GlaxoSmithKline PLC

1,858.5

↓-0.83%
help-icon Live chat